Neuroprotection Market Scope and Size by 2031
The neuroprotection market of is expected to grow with a significant rate in the forecast years, owing to driving factors such as, growing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, rising incidences of CNS diseases, increased demand for more target specific drug treatment for neurodegenerative diseases with favorable government regulations. The increasing healthcare infrastructure, increasing economic stability in developing economies, are likely to offer more opportunities in the neuroprotection market.
The “Global Neuroprotection Market Analysis To 2031” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuroprotection market with detailed market segmentation by product, application and geography. The global neuroprotection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Neuroprotection market.
The global neuroprotection market is segmented on the basis of product and application. Based on product, the neuroprotection market has been segmented into free radical trapping agents (antioxidants), apoptosis inhibitors, anti-inflammatory agents, glutamate antagonists (anti-excitotoxic agents), metal ion chelators and others. The application segment is classified as treatment and prevention.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuroprotection market based on product, application and geography. It also provides market size and forecast till 2031 for overall neuroprotection market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the neuroprotection market in the coming years, owing to factors such as, various market players operate in this region. The European region is expected to hold the second largest market for the neuroprotection. Asia Pacific is anticipated to be the fastest growing market as the due to the growing number of the neurological disorders in the countries, effect of pricing pressure due to grown competition amongst important brands, rise of generic products and growing number of regional players who are able to provide products at much lower prices.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key neuroprotection market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Eli Lilly and Company, Allergan plc, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Biogen Inc., Astrocyte Pharmaceuticals, Inc. and other prominent players. REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. NEUROPROTECTION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neuroprotection Market – By Product
3.2.2. Neuroprotection Market – By Application
3.2.3. Neuroprotection Market – By Region
3.2.3.1. By Country
4. NEUROPROTECTION MARKET – KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. IMPACT ANALYSIS
5. NEUROPROTECTION MARKET – GLOBAL ANALYSIS
5.1. GLOBAL NEUROPROTECTION MARKET OVERVIEW
5.2. GLOBAL NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. FREE RADICAL TRAPPING AGENTS (ANTIOXIDANTS) MARKET
6.3.1. Overview
6.3.2. Free Radical Trapping Agents (Antioxidants) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. APOPTOSIS INHIBITORS MARKET
6.4.1. Overview
6.4.2. Apoptosis Inhibitors Market Revenue Forecasts and Analysis (US$ Mn)
6.5. GLUTAMATE ANTAGONISTS (ANTI-EXCITOTOXIC AGENTS) MARKET
6.5.1. Overview
6.5.2. Glutamate Antagonists (Anti-Excitotoxic Agents) Market Revenue Forecasts and Analysis (US$ Mn)
6.6. ANTI-INFLAMMATORY AGENTS MARKET
6.6.1. Overview
6.6.2. Anti-inflammatory Agents Market Revenue Forecasts and Analysis (US$ Mn)
6.7. METAL ION CHELATORS MARKET
6.7.1. Overview
6.7.2. Metal Ion Chelators Market Revenue Forecasts and Analysis (US$ Mn)
6.8. OTHERS MARKET
6.8.1. Overview
6.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. TREATMENT MARKET
7.3.1. Overview
7.3.2. Treatment Market Revenue Forecasts and Analysis (US$ Mn)
7.4. PREVENTION MARKET
7.4.1. Overview
7.4.2. Prevention Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
8.1. NORTH AMERICA NEUROPROTECTION MARKET OVERVIEW
8.2. NORTH AMERICA NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
8.4. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
8.5. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.6.2. US Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.7.2. Canada Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.8.2. Mexico Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
9.1. EUROPE NEUROPROTECTION MARKET OVERVIEW
9.2. EUROPE NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
9.4. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
9.5. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. France Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Germany Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. UK Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
10.1. ASIA PACIFIC NEUROPROTECTION MARKET OVERVIEW
10.2. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
10.4. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. China Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. India Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Japan Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. South Africa Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Saudi Arabia Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. UAE Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. Brazil Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. NEUROPROTECTION MARKET, KEY COMPANY PROFILES
13.1. ELI LILLY AND COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DR. REDDY’S LABORATORIES LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DAIICHI SANKYO COMPANY, LIMITED
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. F. HOFFMANN-LA ROCHE AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ASTRAZENECA PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOGEN, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ASTROCYTE PHARMACEUTICALS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
1. Eli Lilly and Company
2. Allergan plc
3. Dr. Reddy’s Laboratories Ltd.
4. Teva Pharmaceutical Industries Ltd.
5. Daiichi Sankyo Company
6. Novartis AG
7. F. Hoffmann-La Roche AG
8. AstraZeneca plc
9. Biogen Inc.
10. Astrocyte Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For